Nilai Buku saben Saham: Ascendis Pharma AS (ASND)

Scaling the portfolio of Ascendis Pharma A/S (ASND) appears risky, yet the projected book value per share confirms asset stability. The parameter value stands at 24.88, proving the effective monetization of its unique drug delivery system. The biotech's revenues are based on insurance fund payments for the treatment of rare endocrine pathologies, ensuring steady capital growth for the issuer.

Ascendis Pharma AS (ASND): Nilai Buku Saham saka 04.07.2022 nganti 27.10.2026

ascendispharma.com - rincian analitis lan metrik utama (ASND)

- rega lan prakiraan konsensus rega:

Bagan rega Ascendis Pharma Inc.|ASND - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Kapitalisasi pasar Ascendis Pharma A/S|ASND - Nilai Bisnis

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Ascendis Pharma|ASND - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku ascendispharma.com|ASND - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal Ascendis Pharma A/S|ASND - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ascendis Pharma|ASND - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Ascendis Pharma A/S

Pambiji fundamental perusahaan:Ascendis Pharma Inc. - ASND

Professional capital evaluates the issuer through the prism of the real value of its net assets. This indicator is calculated as the difference between total equity and liabilities, divided by the number of shares. By analyzing the trend in book value per share, an investor sees the actual volume of equity. For Ascendis Pharma A/S (ASND), this reflects the efficiency of investments in prolonged therapies. Steady growth in this metric confirms financial stability prior to scaling production.

Pesaing Ascendis Pharma A/S (ASND)